Serum intact fibroblast growth factor 23 levels are negatively associated with bone mineral density in chronic hemodialysis patients

HIGHLIGHTS

  • who: Wen-Teng Lee et al. from the Division of Nephrology, Department of Internal Medicine, Shin-Kong Wu Ho-Su Memorial Hospital, Taipei, Taiwan Department of Medicine, Catholic University School of Medicine, Taipei, Taiwan have published the research: Serum Intact Fibroblast Growth Factor 23 Levels Are Negatively Associated with Bone Mineral Density in Chronic Hemodialysis Patients, in the Journal: (JOURNAL) of 16/02/2023
  • what: This study was designed to evaluate the association between bone-related serological markers and clinical outcomes in patients receiving CHD. In the present study, continuous data are presented as means . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?